Thick Nails, Palms and Soles

  • Mohammad Ali El-Darouti


A 27-year-old male presented with thickening and hardening of all his 20 nails and palmoplantar keratoderma started at 8-month of age (Figs. 9.1, 9.2, 9.3, 9.4, 9.5, 9.6, and 9.7). His teeth were present at birth and he had no leukokeratosis of oral mucosa, and no eye involvement.


Natal Tooth Corneal Dystrophy Dyskeratosis Congenita Keratin Gene Eccrine Gland 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Blank H. Treatment of pachyonychia congenita with phenytoin. Br J Dermatol. 2006;106:123.CrossRefGoogle Scholar
  2. Bowden PE, Haley JL, Kansky A, et al. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nat Genet. 1995;10:363–78.PubMedCrossRefGoogle Scholar
  3. Clementi M, Cardin de Stefani E, Dei Rossi C, Avventi V, Tenconi R. Pachyonychia congenita Jackson-Lawler type: a distinct malformation syndrome. Br J Dermatol. 1986;114(3):367–70.PubMedCrossRefGoogle Scholar
  4. Connors JB, Rahil AK, Smith FJ, McLean WH, Milstone LM. Delayed-onset pachyonychia congenita associated with a novel mutation in the central 2B domain of keratin 16. Br J Dermatol. 2001;144(5):1058–62.PubMedCrossRefGoogle Scholar
  5. Covello SP, Smith FJ, Sillevis Smitt JH, et al. Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol. 1998;139:475–80.PubMedCrossRefGoogle Scholar
  6. de Berker D, Wojnarowska F, Sviland L, et al. Keratin expression in the normal nail unit: markers of regional differentiation. Br J Dermatol. 2000;142:89–96.PubMedCrossRefGoogle Scholar
  7. El-Darouti MA, Marzouk SA, Nabil N, Abdel-Halim MR, El-Komy MH, Abdel-Latif M. Pachyonychia congenita: treatment of the thickened nails and palmoplantar circumscribed callosities with urea 40 % paste. J Eur Acad Dermatol Venereol. 2006;20(5):615–7.PubMedCrossRefGoogle Scholar
  8. Feinstein A, Friedman J, Schewach-Millet M. Pachyonychia congenita. J Am Acad Dermatol. 1988;19(4):705–11.PubMedCrossRefGoogle Scholar
  9. Haber RM, Rose TH. Autosomal recessive pachyonychia congenita. J Am Acad Dermatol. 1986;122:919–23.Google Scholar
  10. Hannaford RS, Stapleton K. Pachyonychia congenita tarda. Australas J Dermatol. 2000;41:175–7.PubMedCrossRefGoogle Scholar
  11. Jadassohn J, Lewandowsky F. Pachyonychia congenita. Keratosis disseminata circumscripta (follicularis). Tylomata. Leukokeratosis linguae. In: Jacob’s Ikonographia dermatologica. 1. Berlin: Urban und Schwarzenberg; 1906. p. 29–30.Google Scholar
  12. Leachman SA, Kaspar RL, Fleckman P, et al. Clinical and pathological features of pachyonychia congenita. J Investig Dermatol Symp Proc. 2005;10(1):3–17.PubMedCrossRefGoogle Scholar
  13. Liao H, Sayers JM, Wilson NJ, et al. A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita. J Dermatol Sci. 2007;48(3):199–205.PubMedCrossRefGoogle Scholar
  14. McLean WH, Rugg EL, Lunny DP, et al. Keratin 16 and 17 mutations cause pachyonychia congenita. Nat Genet. 1995;9:273–8.PubMedCrossRefGoogle Scholar
  15. Milstone LM, Fleckman P, Leachman SA, et al. Treatment of pachyonychia congenita. J Investig Dermatol Symp Proc. 2005;10(1):18–20.PubMedCrossRefGoogle Scholar
  16. Munro CS. Pachyonychia congenita: mutations and clinical presentations. Br J Dermatol. 2001;144(5):929–30.PubMedCrossRefGoogle Scholar
  17. Sharma VK, Sharma R, Kaus S. Pachyonychia congenita with tuberous sclerosis. Int J Dermatol. 1989;28:332–3.PubMedCrossRefGoogle Scholar
  18. Smith FJD, Jonkman MF, van Goor H, et al. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum Mol Genet. 1998;7:1143–8.PubMedCrossRefGoogle Scholar
  19. Smith FJ, Liao H, Cassidy AJ, et al. The genetic basis of pachyonychia congenita. J Investig Dermatol Symp Proc. 2005;10(1):21–30.PubMedCrossRefGoogle Scholar
  20. Su WP, Chun SI, Hammond DE, et al. Pachyonychia congenita: a clinical study of 12 cases and a review of the literature. Pediatr Dermatol. 1990;7:33–8.PubMedCrossRefGoogle Scholar
  21. Swartling C, Vahlquist A. Treatment of pachyonychia congenital with plantar injections of botulinum toxin. Br J Dermatol. 2006;154:763–5.PubMedCrossRefGoogle Scholar
  22. Terrinoni A, Smith FJ, Didona B, et al. Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita. J Invest Dermatol. 2001;117(6):1391–6.PubMedCrossRefGoogle Scholar
  23. Thomsen RJ, Zuehlke RL, Beckman BL. Pachyonychia congenita. Surgical management of the nail changes. J Dermatol Surg Oncol. 1982;8:24–8.PubMedGoogle Scholar
  24. Tidman MJ, Wells RS. Control of plantar blisters in pachyonychia congenita with topical aluminium chloride. Br J Dermatol. 1988;118(3):451–2.PubMedCrossRefGoogle Scholar
  25. Tidman MJ, Wells RS, MacDonald DM. Pachyonychia congenita with cutaneous amyloidosis and hyperpigmentation: a distinct variant. J Am Acad Dermatol. 1987;16:935–40.PubMedCrossRefGoogle Scholar
  26. Xiao SX, Feng YG, Ren XR, et al. A novel mutation in the second half of the keratin 17 1A domain in a large pedigree with delayed-onset pachyonychia congenita type 2. J Invest Dermatol. 2004;122(4):892–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Mohammad Ali El-Darouti
    • 1
  1. 1.Cairo UniversityCairoEgypt

Personalised recommendations